--It is the Department of Army's intention to award a sole source to CYLEX, Inc., to perform the immune cell function assy to detect levels of intracellular ATP in CD3 cells from blood samples furnished by the USAMRIID.

The U.S. Army Medical Research Acquisition Activity plans to award a sole source purchase order to CYLEX Inc. for conducting an immune cell function assay to measure intracellular ATP levels in CD3 cells using blood samples provided by USAMRIID. This procurement is conducted under FAR 6.302-1 authority, indicating no competitive quotes are requested, although statements of capability from other qualified businesses will be considered if submitted by the specified deadline of August 26, 2005. Interested offerors are required to submit their capability statements via email to the designated contact. The contract involves the specialized scientific analysis of immune cells and falls under the NAICS code 541720, related to research and development services. The procurement is specifically tailored to CYLEX Inc., reflecting their unique qualifications or capabilities for this immune assay. While competition is limited due to the sole source nature of the contract, the government remains open to evaluating other viable providers prior to the deadline. The performance location and detailed organizational contact information are not specified in the notice.